Bringing Advanced Therapies for Parkinson's Disease to the Clinic: An Analysis of Ethical Issues.

Journal of Parkinson's Disease
Kristina Hug

Abstract

Advanced therapies for Parkinson's disease (PD) constitute a broad range of treatments, each presenting specific ethical challenges. Some of these therapies are established and in clinical use, like device-aided therapies, and others, based on advanced therapeutic medicinal products (ATMPs), are still in early stage of clinical trials. This paper focuses on some common ethical issues arising in these two categories of advanced therapies, especially challenges arising when advanced therapies are proposed to PD patients in the form of advanced care, under a clinical trial, or, in case of ATMPs, under the "hospital exemption" rule. The ethical issues covered here relate mainly to ensuring informed consent in these different contexts, to the stakeholder role of patient's non-professional caretakers, such as family, and to patient safety in treatments under "hospital exemption". To illustrate the points discussed in connection with "hospital exemption" rule, the example of the EU has been chosen. This paper does not claim completeness of ethical issues raised by bringing advanced therapies for PD to the clinic, but rather presents examples of ethical challenges in this context.

References

Mar 13, 2012·Neuropsychologia·Stefania de VitoSergio Della Sala
Oct 9, 2014·Cytotherapy·Natividad CuendeUNKNOWN Legal and Regulatory Affairs Committee—Europe, International Society for Cellular Therapy
May 4, 2016·Nature Reviews. Drug Discovery·Yasuhiro Fujiwara
Jul 15, 2016·Current Stem Cell Research & Therapy·Tatjana IvaskieneJustinas Ivaska
Feb 17, 2017·Medicine, Health Care, and Philosophy·Karsten WittChristiane Woopen
Mar 28, 2017·Parkinsonism & Related Disorders·C R Towns
May 5, 2017·Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række·Beriwan EzatEspen Dietrichs
May 31, 2017·International Review of Neurobiology·Jonathan TimpkaAngelo Antonini
Sep 6, 2017·Lancet·Dara Mohammadi
Oct 14, 2017·Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists·Cynthia S Kubu, Paul J Ford
Jan 10, 2018·Development·Malin Parmar
Apr 14, 2018·Progress in Neurobiology·Kai-C SonntagKwang-Soo Kim
May 17, 2018·The Medical Journal of Australia·Anna SauerbierK Ray Chaudhuri
Jul 18, 2018·Acta neurologica Belgica·Patrick SantensMiet De Letter
Jul 22, 2018·Neural Regeneration Research·Chang-Geng SongHua Han
Oct 18, 2018·Expert Review of Neurotherapeutics·Junaid SiddiquiJawad A Bajwa
Jan 12, 2019·Journal of Medical Ethics·Jonathan Pugh
Apr 17, 2019·Enfermería clínica·Diego Durán BermejoYago Mouriño López
Jan 20, 2017·Geriatrics·James Alvin Low, Esther Ho
Sep 20, 2019·Neural Regeneration Research·Theo Stoddard-Bennett, Renee Reijo Pera
Nov 14, 2019·Neural Regeneration Research·Rocío Fernandez-SerraDaniel González-Nieto
Dec 5, 2019·NPJ Parkinson's Disease·Leonard L SokolMoran Cerf
Apr 26, 2020·Journal of Parkinson's Disease·Patrick Bodilly KaneJonathan Kimmelman
May 5, 2020·Journal of Empirical Research on Human Research Ethics : JERHRE·Lauren OlsenJohn H Evans
May 16, 2020·Journal of Medical Ethics·Frederic Gilbert, Mathilde Lancelot
Jul 1, 2020·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·A G Jaramillo VélezP Modamio
Aug 3, 2020·Current Neurology and Neuroscience Reports·Neha Prakash, Tanya Simuni
Aug 28, 2020·Frontiers in Cellular Neuroscience·Cristina Salado-ManzanoJosep M Canals

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2021 Meta ULC. All rights reserved